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Abstract
Objective
After one previous caesarean section (CS), pregnant women can deliver by elective repeat
CS or have a trial of labor which can end in a vaginal birth after caesarean (VBAC) or an
unplanned CS. Despite guidelines describing women’s rights to make an informed choice,
trial of labor and VBAC rates vary greatly worldwide. Many women are inadequately
informed due to caregivers’ fear of an increase in CS rates in a high VBAC rate setting. We
compared counseling with a decision aid (DA) including a prediction model on VBAC to care
as usual. We hypothesize that counselling with the DA does not decrease VBAC rates. In
addition, we aimed to study the effects on unplanned CS rate, patient involvement in deci-
sion-making and elective repeat CS rates.
Methods
We performed a prospective cohort study. From 2012 to 2014, 483 women in six hospitals,
where the DA was used (intervention group), were compared with 441 women in six
matched hospitals (control group). Women with one previous CS, pregnant of a singleton in
cephalic presentation, delivering after 37 weeks 0 days were eligible for inclusion.
Results
There was no significant difference in VBAC rates between the intervention (45%) and con-
trol group (46%) (adjusted odds ratio 0,92 (95% Confidence interval 0.69–1.23)). In the
intervention group more women (42%) chose an elective repeat CS compared to the control
group (31%) (adjusted odds ratio 1.6 (95% Confidence interval 1.18–2.17)). Of women
choosing trial of labor, in the intervention group 77% delivered vaginally compared to 67% in
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protocol and design, they were not involved in
the control group, resulting in an unplanned CS adjusted odds ratio of 0,57 (0.40–0.82) in
the intervention group. In the intervention group, more women reported to be involved in
decision-making (98% vs. 68%, P< 0.001).
Conclusions
Implementing a decision aid with a prediction model for risk selection suggests unchanged
VBAC rates, but 40% reduction in unplanned CS rates, increase in elective repeat CS and
improved patient involvement in decision-making.
Introduction
After one previous caesarean section (CS), pregnant women can deliver by elective repeat cae-
sarean section (ERCS) or have a trial of labor (TOL) which can end in a vaginal birth after cae-
sarean (VBAC) or an unplanned CS. Despite guidelines describing women’s rights to make an
informed choice and that for most women vaginal birth is safe [1–3], TOL and VBAC rates
vary greatly worldwide [4]. In the United States (US), the VBAC rate is around 8.3% [5]. In
2015, 1.3 million women in the US underwent a CS (32%) [6], making it one of the most fre-
quently performed operative interventions in women. In The Netherlands, VBAC rates are
much higher (54%) [7], but most women are inadequately informed about their choices due to
caregivers’ fear of an increase in CS rates [8]. Morbidity risks (both maternal and neonatal) are
directly related to the individual probability of VBAC since morbidity is lowest in women with
VBAC, but higher in women with unplanned than planned CS [9]. We developed a decision
aid (DA) containing evidence based information including a prediction model [10, 11]. A bet-
ter inventory of risks, benefits and chance of success might improve shared decision making
and reduce unplanned CSs without bringing down the number of VBAC.
We aimed to evaluate the effect of counseling with a decision aid (DA) including a predic-
tion model compared to regular counseling without the DA on the VBAC-rate. We hypothe-
size that counseling with the DA does not decrease VBAC rates (i.e. non-inferiority with
respect to VBAC rate). In addition, we aimed to study the effects on unplanned CS rate, patient
involvement in decision-making, ERCS rate, guideline adherence and maternal and neonatal
complications.
Materials and methods
Study design & setting
We performed a prospective cohort non-inferiority study: we hypothesised that counseling
with the DA does not decrease VBAC rates. In a preliminary study in 2010 [12], VBAC and
TOL rates in 17 hospitals in the Netherlands were studied as part of the SIMPLE I study. For
this current study (SIMPLE II), twelve of these hospitals were selected based on type of hospital
(university, teaching and non-teaching hospitals) and their 2010 VBAC rates (<percentile (p)
20, p20-80 and>p80) and divided into six matched pairs based on these criteria. The groups
had a comparable VBAC rate in the pre-measurement (46 vs 53%, non-significant). In the
period between September 2012 and September 2014, we applied our DA in six of the hospitals
(intervention hospitals) in one region, and compared VBAC rates and the secondary outcomes
with the six matched hospitals providing counseling without the DA (control hospitals) (S1
File).
Effect of a decision aid on mode of delivery after caesarean
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This design was chosen based on different facts. There is close collaboration between hospi-
tals and midwifery practices in a small country as the Netherlands. Midwifery practices may
work with several hospitals in one region. In this study setting referring midwives would not
have to deal with two policies, with chance of bias. Besides, caregivers like residents who work
in different settings in one region during their specialization were not biased by knowledge of
the use of the DA when they switch to another hospital.
The study was a consecutive study of the previously reported SIMPLE study [8]. The study
was initially designed as a controlled before and after study with an intervention trial incorpo-
rated in the second part. When reporting the results, this created an overcomplicated method
section with no added value to the results. In this final design, data from the before measure-
ment were used to select two comparative groups of hospitals (S1 Table). In this setting the
prospective intervention trial was performed, improving clarity of the study.
Study population
All women with a singleton pregnancy and a foetus in cephalic position, delivering after 37
weeks after one previous CS, without a contra-indication for a TOL, were eligible for inclusion.
The DA was developed as a tool to improve guideline adherence. Therefore the Medical Ethi-
cal Committee of the MUMC+ agreed that no individual informed consent was needed for
receiving the DA (the DA was assigned at hospital level). The DA was administered to all eligi-
ble women in only the intervention hospitals. Informed consent was only needed and obtained
from the patients (with command of the Dutch language), who were willing to complete the
questionnaire.
Intervention
We developed a DA for mode of delivery after previous CS including a prediction model for
predicting the individual probability of a VBAC. The content was based on literature search,
expert’s opinion and the contemporary international guidelines on delivery after previous CS
[11]. Seven steps essential for decision-making in mode of delivery were included: preferences
for mode of delivery before reading the DA (1), previous birth experiences (2), risks and bene-
fits of TOL and ERCS (including the prediction model)(3), a worksheet to weigh out the
options (4), a birth plan where women can write down their preferences (5), preliminary
choice (6) and follow-up to reevaluate the decision (7). The DA was developed according to
the IPDAS criteria and pilot tested in 25 women.
A woman’s individual probability on a VBAC was calculated with a previously developed
prediction model [10]. This model was developed for a West-European population and
includes indication for previous CS, body mass index (BMI), need for labor induction, ethnic-
ity, estimated fetal weight in the current pregnancy and a previous vaginal delivery. Our data-
base was too small to determine a cut-off level in individual probability on VBAC and in
temporary literature there is no evidence for a specific cut-off level. For this reason we did not
present a cut-off level, giving women a possibility to weigh their own probability. Women in
the intervention hospitals received the DA before 36 weeks of pregnancy were able to read and
discuss it with relevant others before discussing the mode of delivery with their obstetrical
caregiver. During consultation around 36 weeks the DA was used as guidance of the counsel-
ing for mode of delivery and shared decision making and the prediction model was filled in.
The woman’s individual probability on a VBAC was then showed in a percentage. At this
point a shared decision was made on the mode of delivery. During this consultation women
were asked for informed consent for completing the questionnaire send by email. The counsel-
ing was repeated if the circumstances changed (for example when labor induction was
Effect of a decision aid on mode of delivery after caesarean
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needed). In each intervention hospital, an one-hour training for healthcare professionals was
organized to discuss the content of the DA and to instruct how to use the DA in daily practice.
In the control hospitals, patients received according to the contemporary guideline oral and/
or written information on mode of delivery after CS as usual from their obstetrician or midwife
during regular consultations in their pregnancy. According to the contemporary Dutch guide-
line women should be informed about the chance of a VBAC, the risk of a uterine rupture, the
increased risk of a uterine rupture in use of oxytocin or prostaglandins, the risks and advantages
of an ERCS, the implications for a possible next pregnancy and the policy in case of spontaneous
labor. The discussion on mode of delivery also took place around 36 weeks during consultation.
The DA and the prediction model were not used in the control group.
Outcome measures
The primary outcome was the VBAC-rate. Secondary outcomes were unplanned CS rate,
patient involvement in decision-making, ERCS rate, guideline adherence for counseling and
maternal and neonatal complications. Patient involvement was defined as a positive answer to
the question if a woman felt involved in the decision making regarding the choice of mode of
delivery. This question was part of a validated questionnaire, used for other studies as well
[13].
Guideline adherence was defined as mentioning in the patient chart discussing the follow-
ing items: risk of uterine rupture, the increased risk of uterine rupture when using oxytocin or
prostaglandins, the chance of VBAC, and risk of perinatal mortality. Maternal complications
included more than 4 packed cells, uterine rupture, hysterectomy, operational injury, throm-
bosis, maternal death and admission to the intensive care unit. Neonatal complications
included neonatal death, neonatal asphyxia, plexus lesion of fracture and admission to the neo-
natal intensive care.
Sample size
We hypothesised an equal VBAC rate between the intervention and control group and consid-
ered a decrease in VBAC rate of over 10% in the intervention group undesirable. Therefore, a
non-inferiority limit of 10% was chosen. Consequently, a VBAC rate of more than 10% reduc-
tion in the intervention group compared to the control group would be seen as ‘inferior ‘care.
In 2010 the SIMPLE study showed a national VBAC rate of 49% [12]. The necessary sample
size for showing non-inferiority, with an alpha of 0.05, a beta of 0.20, and an intra-cluster cor-
relation coefficient (ICC) of 0.2, was 400 per study-arm.
Each hospital was asked to prospectively include 80 consecutive eligible women. The partici-
pating hospitals were requested to administer questionnaires to a convenience sample of 30 of
the 80 eligible patients during the study-period. This sample size was based on a needed number
for measuring decisional conflict also measured with this validated questionnaire [13] also used
for other studies. The Ottawa Health Decision Centre indicates that an effect size of 0.3–0.4 is
meaningful [14]. We chose an alpha of 0.05, a beta of 0.20 and a standard deviation of 17.5 [15].
Therefore, for detecting an effect size of at least 0.3, a difference between DC scores of 5.25
between the intervention group and the control group was needed. We estimated the ICC to be
0.2. The estimated sample size, corrected for cluster variation, was 200 per study arm.
Data collection
Data on VBAC, unplanned CS and ERCS were collected from the medical records and
national perinatal registry by trained staff using case report forms. A validated questionnaire
was used to ask among other things, whether patients felt involved in the decision making
Effect of a decision aid on mode of delivery after caesarean
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regarding the choice of mode of delivery [13]. The questionnaire was handed out to the
patients online at 37 weeks of pregnancy after informed consent. Patients were instructed to
fill in the questionnaire after discussing and having decided upon mode of delivery with their
obstetric caregiver. The variables of guideline adherence (risk of uterine rupture, the increased
risk of uterine rupture when using oxytocin or prostaglandins, the chance of VBAC, and risk
of perinatal mortality) were measured according to their frequency of documentation in the
medical records. Data on maternal complications(more than 4 packed cells, uterine rupture,
hysterectomy, operational injury, thrombosis, maternal death and admission to the intensive
care unit) and neonatal complications (neonatal death, neonatal asphyxia, plexus lesion of
fracture and admission to the neonatal intensive care) were extracted from medical records
and the national perinatal registration. Information on actual use of the DA, demographic fac-
tors, obstetric history, and current pregnancy (co-variables) to check if the intervention group
and control group were comparable, was extracted from medical records and the national peri-
natal registry.
Statistical analyses
Data analysis was carried out using SPSS 21. All consecutive eligible women were included in
the statistical analysis, irrespective of their actual exposure to the DA. Only the women, who
gave informed consent for the questionnaire, received the questionnaire. The data were
entered in the study database by study staff. In case of inconsistencies, data were checked with
the hospital concerned. Missing covariable data were imputed using stochastic regression
imputation, since complete case analysis may decrease statistical power and induce bias if data
are not ‘missing’ completely at random.
In order to study the effects of the DA, data analysis was performed according to intention-
to-treat and per-protocol principle (women actually receiving the DA). Non-inferiority was
analysed by converting the non-inferiority limit of 10% (in relative risk) to a limit in odds ratio
(OR) on VBAC in the intervention group compared to the control group. The OR’s for VBAC
were calculated by multivariable regression analysis, correcting for the variables of the predic-
tion model and age. To check for non-inferiority, the 95% confidence interval (CI) of the OR
was then assessed with the non-inferiority limit. If the 95% CI limits were exceeding the non-
inferiority limit, non-inferiority cannot be proven. The same procedure for calculating OR
was followed for the unplanned CS rate. Differences in patient involvement and guideline
adherence between women in the intervention and control group were tested using chi-square.
The relative risks estimates for complications were calculated using cross-tabs.
Details of ethical approval
Ethical approval for this study was obtained from the Medical Ethical Committee of Maastricht
University Medical Centre+ in The Netherlands (MEC number 12-4-091) (25-07-2012). The
study started in September 2012. Local approval was received from the boards of directors of
local hospitals. Written informed consent was obtained from the patients willing to complete
the questionnaire. The DA was developed as a tool to improve guideline adherence. Therefore
the Medical Ethical Committee of the MUMC+ agreed that no individual informed consent
was considered needed for this part of the study.
Trial registration
This study is registered at ClinicalTrials.gov: Current Dutch Practice on Caesarean Sections:
Identification of Barriers and Facilitators for Optimal Care (SIMPLE), NCT01261676, https://
clinicaltrials.gov//show/NCT01261676?term=cesarean&rank=18
Effect of a decision aid on mode of delivery after caesarean
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Results
Baseline characteristics
Table 1 shows that baseline characteristics of the women in the intervention- and control-
group were mostly comparable. In the intervention group women were a bit younger and had
a shorter pregnancy, less women had a previous CS due to failure to progress and more
women had a previous vaginal birth, however this difference was not significant.
Main outcome
We analyzed 924 women, 483 in the intervention group and 441 in the control group, respec-
tively (Fig 1). All consecutive eligible women were included in each hospital, except for one
control hospital due to bankruptcy (45 women included). No women were excluded. There
was no difference in VBAC rates between the intervention and control group (45 vs. 46%).
The crude odds-ratio (OR) for VBAC for the intervention group compared to the control
group, was 0,96 (95% CI 0,74–1,24). When correcting for differences in predictors of the pre-
diction model in both groups, the adjusted OR was 0,92 (95% CI 0.69–1,23) (Table 2). We also
corrected for other possible predictors of VBAC: pre-eclampsia or the syndrome of hemolysis,
elevated liver enzymes, and low platelet count (HELLP), hypertension and diabetes in the cur-
rent pregnancy and maternal age based on previous studies [10], with unchanged outcome.
To test non-inferiority for VBAC, we used a non-inferiority limit of 10% (RR 0.9 in case of
a decrease in VBAC) which was converted into a limit in OR. Based on a prevalence of 46% of
VBAC in the control group, the non-inferiority limit for the OR was 0.83. The 95% CI of both
the crude OR (0.96 (95% CI 0.74–1.24)) and the adjusted OR (0,92 (95% CI 0.69–1,23)) for
VBAC crossed the non-inferiority limit in the intention to treat analysis. Therefore, even
Table 1. Baseline characteristics.
Intervention group
(N = 483)
Control group
(N = 441)
p-value/test
N/Mean %/range/SD Missing N/Mean (%/range/SD Missing
Demographic
factors
Caucasian, (%) 395 82,2% 3 343 78,3% 3 0,14/chis
Maternal age (years) 33,33 ±4,35 6 33,9 ±4,53 24 0,06/t-test
BMI (kg/m2) 67 94 �
<20 44 10,6% 32 9,2% 0,55/ chis
20–24,9 165 39,7% 142 40,9% 0,77/ chis
25–34,9 174 41% 149 42,9% 0,90/chis
>35 33 7,9% 24 6,9% 0,68/ chis
Obstetric history
Parity 1,32 0,77 2 1,29 0,68 3 0,83/ MW
Indication previous CS failure to progress 192 44,1% 48 201 47,1% 14 0,41/ chis
Previous vaginal birth 91 19,0% 5 73 16,7% 3 0,39/ chis
Current pregnancy
Gestational age (in days) 276,20 8,09 277,23 7,83 0,044/MW
Estimated fetal weight from GA 32 weeks p�90 27 6,4% 59 33 7,6% 6 0,51/ chis
Induction of labor 90 21,5% 65 94 25,4% 71 0,21/ chis�
SD: standard deviation, chis: chi-square, BMI: body mass index, MW: Mann-Whitney-U test, CS: caesarean section, GA: gestational age, p: percentile
� missing data > 10%
https://doi.org/10.1371/journal.pone.0222499.t001
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Fig 1. Consort flow diagram. Enrollment, allocation, follow-up and analysis.
https://doi.org/10.1371/journal.pone.0222499.g001
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though the point estimate suggests that the use of the DA did not decrease VBAC beyond the
non-inferiority limit, the results are not conclusive because of the wide confidence intervals.
This occurred in the per-protocol analysis as well, where the crude OR was 1.1 (95% CI 0.81–
1.49). In the intervention-group 269/483 (56%) of the women received the DA. In the per-pro-
tocol analysis the VBAC rates were comparable as well (48% vs. 46%). The predicted chance of
succeeding in VBAC was comparable in women who received the DA and who did not receive
the DA in the intervention group (p = 0,95).
Secondary outcomes
Table 3 shows the results of the different onsets of delivery. In the intervention group more
women chose an ERCS (42%) compared to the control group (31%), (adjusted OR 1.6 [95% CI
1.18–2.17]) (intention to treat analysis). Of the women starting a TOL, in the intervention
Table 2. Mode of delivery outcome.
Intention to treat Per-protocol DA vs. control group
Intervention
(N = 483) (%)
Control
(N = 441) (%)
Crude OR
(95% CI)
Adjusted OR (95% CI)
(corrected for
risk factors)
Intervention
(N = 269) (%)
Crude OR
(95% CI)
Adjusted OR (95% CI)
(corrected for
risk factors)
Mode of delivery
Elective repeat caesarean delivery 201 41,6% 137 31,1% 1,6
(1,21–2,07)
1,6 (1,18–2,17) 112 41,6% 1,6
(1,16–2,17)
1,6
(1,14–2,32)
Spontaneous delivery 182 37,7% 167 37,9% 0,99
(0,76–1,30)
0,95
(0,71–1,28)
108 40,1% 1,1
(0,81–1,50)
1,1
(0,76–1,51)
Instrumental delivery 35 7,2 36 8,2% 0,88
(0,54–1,42
0,91
(0,57–1,48)
22 8,2% 1,0
(0,58–1,74)
1,0
(0,58–1,79)
Unplanned caesarean section 65 13,5% 101 22,9% 0,52
(0,37–0,74)
0,57
(0,40–0,82)
27 10,0% 0,38
(0,24–0,59)
0,41
(0,26–0,66)
Intended vaginal birth (trial of labor) 282 58,4% (282/483) 304 68,9%
(304/441)
0,63
(0,48–0,83)
0,63
(0,46–0,85)
157 58,4% 0,63
(0,46–0,87)
0,62
(0,43–0,88)
Vaginal birth of those with a trial of labor 217 76,9% (217/282) 203 66,8%
(203/304)
1,7
(1,15–2,39)
1,4
(0,96–2,12)
130 82,8% 2,4
(1,49–3,87)
2,0
(1,17–3,28)
Total VBAC rate 217 44,9%
(217/483)
203 46,0%
(203/441)
0,96
(0,74–1,24)
0,92
(0,69–1,23)
130 48,3% 1,1
(0,81–1,49)
1,1
(0,77–1,50)
OR: odds ratio, CI: confidence interval, VBAC: vaginal birth after caesarean
https://doi.org/10.1371/journal.pone.0222499.t002
Table 3. Onset of delivery outcome.
Intention to treat Per-protocol DA vs. control group
Intervention
(N = 483) (%)
Control
(N = 441) (%)
Crude OR
(95% CI)
Adjusted OR (95% CI)
(corrected for
risk factors)
Intervention
(N = 269) (%)
Crude OR
(95% CI)
Adjusted OR (95% CI)
(corrected for
risk factors)
Onset labor
Elective repeat caesarean section 201 41,6% 137 31,1% 1,6
(1,21–2,07)
1,6
(1,18–2,17)
112 41,6% 1,6
(1,16–2,17)
1,6
(1,14–2,32)
Spontaneous onset 184 38,1% 207 46,9% 0,70
(0,54–0,90)
0,58
(0,43–0,78)
100 37,2% 0,67
(0,43–0,88)
0,60
(0,42–0,86)
Priming with balloon catheter 45 9,3% 35 7,9% 1,2
(0,75–1,89)
1,8
(1,01–3,05)
21 7,8% 0,98
(0,56–1,73)
1,4
(0,68–2,67)
Priming with prostaglandins 3 0,6% 1 0,2% 2,8
(0,29–26,54)
3,1
(0,29–32,20)
2 0,7% 3,3
(0,30–36,52)
3,6
(0,31–41,37)
Induction 50 10,4% 61 13,8% 0,72
(0,48–1,07)
0,77
(0,46–1,29)
34 12,6% 0,90
(0,58–1,41)
0,82
(0,44–1,50)
OR: odds ratio, CI: confidence interval, VBAC: vaginal birth after caesarean
https://doi.org/10.1371/journal.pone.0222499.t003
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group the vaginal delivery rate was higher (77%), compared to the control group (67%)
(adjusted OR 1.4 [95% CI 0.96–2.12]) (Table 2). Subsequently, even after correction, the
unplanned CS rate was lower in the intervention group (14%) compared to the control group
(23%) (adjusted OR 0.57 [95% CI 0.40–0.82]). The per-protocol analysis showed similar
results; the adjusted OR for an unplanned CS in the intervention group was 0.41 [95% CI
0.26–0.66]. In total 130/269 women chose for a TOL and 83% had a VBAC compared to 67%
in the control group (adjusted OR 2.0 [95% CI 1.17–3.28]).
Regarding decision making, 256 out of 367 women (n = 205 in intervention group and
n = 162 in control group), filled in the questionnaire. Unfortunately, not all caregivers handed
out the questionnaire and not all women replied, in spite of several reminders. In the interven-
tion group 133 out of 137 (98%) stated they were involved in the choice for the mode of deliv-
ery, compared to 78 out of 119 (68%) in the control group (p< 0.001).
Table 4 shows the guideline adherence results based on intention to treat analysis. In the
intervention group, counseling on mode of delivery was more frequently reported in the medi-
cal record (73% vs. 63%, p< 0.001), as were the specific required items (p<0.05). Of course, in
a per-protocol analysis, all women received adequate information.
Table 5 shows the complication rates, which overall were low. When analyzing the total
major complication rate, no significant differences were seen in uterine ruptures, perinatal
deaths and asphyxia. The incidence of neonatal infection and the necessity for antibiotic treat-
ment in women postpartum was comparable as well.
Discussion
Main findings
This study showed that using the DA for the counseling on mode of delivery, does not result
in a change in VBAC rates in a setting with a high VBAC rate. Less women chose a TOL,
however the undesirable event of an unplanned CS was much less common. Although sta-
tistically non inferiority could not be proven and a change in VBAC incidence cannot
completely be ruled out, we found an important shift from unplanned to planned CS.
Women receiving the DA and choosing TOL in the intervention group succeeded more
often than women choosing TOL in the control group. Women who received the DA felt
more involved and were more often counseled according to the guidelines. This shows that
the implementation of our DA results in a better risk-based choice of delivery and a more
personalized counseling.
Table 4. Guideline adherence.
Intention to treat Per protocol
Items guideline adherence Intervention group
(N = 483)
Control group
(N = 441)
p-value Intervention group
(N = 269)
Control group
(N = 655)
p-value
Counseling documented in medical file 353(73%) 278 (63%) p = 0.01 269 (100%) 362 (55,3% p<0,001
p<0,001
Chance of VBAC discussed 295 (61,1%) 141(32,0%) p<0,001 269 (100%) 167 (25,5) p<0,001
Small risk of uterine rupture discussed 288 (59,8%) 183 (41,5% p<0,001 269 (100%) 202 (30,8%) p<0,001
Risk perinatal death discussed 282 (58,4%) 118 (26,8%) p<0,001 269 (100%) 131 (20%) p<0,001
Increased risk of uterine rupture in use of
oxytocin or prostaglandins discussed
286 (59,2%) 185 (42,0%) p<0,001 269 (100%) 202 (30,8%) p<0,001
VBAC: vaginal birth after caesarean
https://doi.org/10.1371/journal.pone.0222499.t004
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Strengths and limitations
This is the first study evaluating the use of a DA with a prediction model for mode of delivery
after CS in a prospective, comparative setting. Several prediction models concerning vaginal
birth after CS have been developed in the past [16–29]. However, none has been tested in prac-
tice as part of counseling. The DA itself was earlier tested according to the International
Patient Aid Standards (IPDAS) and met 39/50 criteria [11, 30] because effectiveness measure-
ments were not performed yet. By using it in a prospective setting the effectiveness can be eval-
uated as well. Taking this into account, the DA meets 46/50 IPDAS criteria [30]. Furthermore,
our study included a large group of patients from different types of hospitals.
The design of our study was a prospective cohort study. Selection of the intervention hospi-
tals was based on geographical region and VBAC results in usual care, which may cause bias.
The reason this design was chosen instead of a cluster randomized trial is the fact that in a
small country as the Netherlands, there is close collaboration between hospitals and midwifery
practices. In this study setting referring midwives would not have to deal with two policies.
Besides, caregivers like residents who work in different settings in one region during their spe-
cialization were not biased by knowledge of the use of the DA. A randomized controlled trial
on patient level was not possible due to effects on knowledge and information bias by
caregivers.
Only 56% of the women in the intervention group received the DA, which can be explained
by the fact that caregivers did not have sufficient attention to the DA in spite of instructions.
To study the effect of the intervention as a whole and specifically the use of a DA, we per-
formed both per-protocol analysis of the women who actually received the DA, and an inten-
tion-to-treat analysis showing that the effects were highest in women actually receiving the
Table 5. Incidence major complications.
Intervention group
(n = 483) (%)
missing Control group
(n = 441) (%)
missing Relative risk
Major maternal complications
> 4 packed cells 0 0% 7 1 0,2% 0 Na.
Uterine rupture 6 1,2% 0 2 0,5% 0 2,7 (0,56–13,50)
Hysterectomy 0 0% 0 0 0% 0 Na.
Operational injury 0 0% 0 2 0,5% 1 Na.
Thrombosis 0 0% 0 1 0,2% 2 Na.
Maternal death 0 0% 0 0 0% 0 Na.
Admission ICU 1 0,2% 7 2 0,5% 3 0,46 (0,04–5,06)
total 7 8
Patients with 1 or more maternal complications 7 1,5% 10 6 1,4% 6 1,1 (0,36–3,17)
Major neonatal complications
Neonatal death 0 0% 0 2 0,5% 2 Na.
Neonatal asphyxia 20 4,1% 5 20 4,6% 4 0,91 (0,50–1,66)
Plexus lesion or fracture 0 0% 5 0 0% 2 Na.
Admission NICU 9 1,9% 15 11 2,5% 7 0,76 (0,32–1,81)
total 29 33
Patients with 1 or more neonatal complications 26 5,6% 16 25 5,8% 11 0,96 (0,56–1,63)
Total major complications 36 41
Patients with 1 or more major complications 31 6,7% 21 27 6,4% 17 1,05 (0,64–1,74)
Na.: not applicable, ICU: intensive care unit, NICU: neonatal intensive care unit
https://doi.org/10.1371/journal.pone.0222499.t005
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DA, but also were present in women that did not. This means that also effects on hospital level
are present suggesting improved knowledge of caregivers or the use of the prediction model
without the DA. As a result of the lack of compliance in the intervention group, differences
between the groups are likely attenuated, leading to an lower statistical power than anticipated.
However, Table 2 shows that most clinically relevant associations, quantified as odds ratios,
are accompanied by relatively small confidence intervals, and differences with respect to guide-
line adherence (Table 4) are all highly significant. This shows that the study still had sufficient
power to detect meaningful differences between groups.
Only 256 out of 367 women who received the questionnaire, returned it, in spite of several
reminders.
Although underpowered, no difference in the total incidence of complications between the
two groups was observed. In general, complication risks are expected to be higher in an
unplanned CS compared to elective CS a [9]. A benefit of using the DA on complication rate
has to be studied in future research.
Interpretation
International guidelines stress that individual characteristics and preferences of the patient
should be taken into consideration when counseling for mode of delivery [1–3]. The individual
probability for a VBAC is a main determinant for the risk of severe maternal morbidity and an
important factor in the decision making process. This study showed that women in the interven-
tion group choosing for TOL more often succeeded in VBAC. This might be an effect of the cal-
culated individual probability, leading to a choice for TOL when the chance on VBAC is high.
This would contribute to better risk selection. The effect of the DA and the prediction model was
analyzed as one single intervention. Consequently, it is difficult to determine whether the results
are due to the prediction model or improved counseling. However, according to the temporary
guidelines women should be informed about their chance on VBAC. Discussing their individual
probability is therefore inseparable from adequate counseling. There was no selection bias in
women who received the DA, when the predicted chances in both groups were similar. One of
our future studies will focus on the impact of the use of the prediction model.
A DA is an effective instrument to support the shared decision-making process and helps
patients to make an informed choice. In our study women who received the DA felt more
involved in the decision making, however this was not tested in the before-setting. Stacey et al.
showed that patients felt more involved in the decision making process when a DA was used
[31]. Shorten et al. showed increased knowledge and less decisional conflict in patients using a
DA [32]. Montgomery et al. also showed reduced decisional conflict in women after using a
DA, but no clear differences in mode of delivery [33]. Horey et al. reported no difference in
preferred mode of delivery after interventions for supporting decision making [34]. Gardner
et al. showed an increase in VBAC after implementation of two other strategies: a standing
team of three high-risk consultants and a antenatal clinic for counseling women for mode of
delivery after caesarean during three visits [35]. To the best of our knowledge this is the first
study showing a change in not only the preferred mode of delivery but also in the actual mode
of delivery after the use of a DA (more ERCS, less unplanned CS). These differences can be
explained by the risk selection due to the incorporation of the prediction model. Besides the
role in the decision making process, the DA can help caregivers to inform patients according
to the guidelines. In spite of the implementation of our intervention and a rise in counseling
according to the guideline, there is still no complete guideline adherence in the intervention
group. This might be due to the fact that the use of the DA was still in the implementation
phase and the fear of caregivers for a rise in CS rate when counseling adequately.
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The effects of the intervention in countries like the US, with an a priori low VBAC-rate are
unclear. Patients possibly have other preferences, but particularly the cultural background and
the preference of the healthcare providers might play a role. Besides, in this study, most of the
women were Caucasian, who are more likely to delivery vaginally compared to Hispanic or
African American women [4]. However, it is not unlikely that in countries with a lower VBAC
rate or other ethnicities, the use of a DA may also lead to a distinct decrease in CS.
Conclusions
In a setting with a high VBAC rate, a patient DA for mode of delivery after CS, appear to result
in similar VBAC rates, but further research is necessary to prove non-inferiority. However, we
found a higher successful TOL a lower unplanned CS rate and a higher ERCS rate. This sug-
gests an improved risk selection.
Supporting information
S1 File Study protocol. Cesarean Section IMPLEmentation (SIMPLE) II Study.
(DOC)
S2 File TREND checklist. (Transparent Reporting of Evaluations with Nonrandomized
Designs).
(PDF)
S3 File. Database.
(SAV)
S1 Table. Overview of VBAC-rates per hospital before and after the intervention per hos-
pital.
(DOCX)
Acknowledgments
Members of the SIMPLE study group
Ben-Willem Mol, Department of Obstetrics and Gynaecology, The Robinson Research
Institute of Paediatrics and Reproductive Health, University of Adelaide and The South Aus-
tralian Health and Medical Research Institute, Adelaide, Australia
Robert Aardenburg, Department of Obstetrics and Gynaecology, Zuyderland Medical Cen-
tre, Sittard, The Netherlands
Friso Delemarre, Department of Obstetrics and Gynaecology, Elkerliek Hospital, Helmond,
The Netherlands
Carmen Dirksen, Department of Clinical Epidemiology and Medical Technology Assess-
ment (KEMTA), Maastricht University Medical Centre+, Maastricht, The Netherlands
Ivo van Dooren, Department of Obstetrics and Gynaecology, Sint Jans Gasthuis, Weert,
The Netherlands
Simone MI Kuppens, Department of Obstetrics and Gynaecology, Catharina Hospital,
Eindhoven, The Netherlands
Anneke Kwee, Department of Obstetrics and Gynaecology, University Medical Centre
Utrecht, Utrecht, The Netherlands
Josje Langenveld, Department of Obstetrics and Gynaecology, Zuyderland Medical Centre,
Heerlen, The Netherlands
Luc J Smits, Caphri School for Public Health and Primary Care, Maastricht University,
Maastricht, The Netherlands
Effect of a decision aid on mode of delivery after caesarean
PLOS ONE | https://doi.org/10.1371/journal.pone.0222499 September 26, 2019 12 / 15
The authors would like to thank the following persons for their substantive contribution to
this study:
Dorien Hunen, MD, dorienhunen@gmail.com
• data collection, research student at Maastricht University, no funding, no conflicts of
interest.
Anouk van den Bosch, MD, a.vdbosch@hotmail.com
• data collection, research student at Maastricht University, no funding, no conflicts of
interest.
All the patients who participated in our study
Study protocol
Melman, S., E.N. Schoorel, C. Dirksen, et al., SIMPLE: implementation of recommendations
from international evidence-based guidelines on caesarean sections in the Netherlands. Protocol
for a controlled before and after study, Implement Sci, 2013. 8: 3.
Author Contributions
Conceptualization: Ellen Schoorel, Sander van Kuijk, Jan Nijhuis, Rosella Hermens, Huber-
tina Scheepers.
Data curation: Ellen Schoorel.
Formal analysis: Emy Vankan, Sander van Kuijk, Rosella Hermens.
Funding acquisition: Hubertina Scheepers.
Investigation: Emy Vankan, Ellen Schoorel, Rosella Hermens, Hubertina Scheepers.
Methodology: Emy Vankan, Ellen Schoorel, Rosella Hermens, Hubertina Scheepers.
Project administration: Ellen Schoorel.
Supervision: Jan Nijhuis, Rosella Hermens, Hubertina Scheepers.
Validation: Emy Vankan, Sander van Kuijk.
Visualization: Emy Vankan, Hubertina Scheepers.
Writing – original draft: Emy Vankan.
Writing – review & editing: Emy Vankan, Ellen Schoorel, Sander van Kuijk, Jan Nijhuis,
Rosella Hermens, Hubertina Scheepers.
References
1. ACOG Practice bulletin no. 115: Vaginal birth after previous cesarean delivery. Obstet Gynecol, 2010.
116(2 Pt 1): 450–63. https://doi.org/10.1097/AOG.0b013e3181eeb251 PMID: 20664418
2. NICE, Caesarean Section, clinical guideline. 2011, London: National Collaborating Centre for
Women’s and Children’s Health.
3. RCOG, Birth after previous caesarean birth. Green-Top Guideline, 2015.
4. Guise JM, Eden K, Emeis C, Denman MA, Marshall N, Fu RR et al. Vaginal birth after cesarean: new
insights. Evid Rep Technol Assess (Full Rep), 2010(191): 1–397.
Effect of a decision aid on mode of delivery after caesarean
PLOS ONE | https://doi.org/10.1371/journal.pone.0222499 September 26, 2019 13 / 15
5. MacDorman M, Declercq E, Menacker F, Recent trends and patterns in cesarean and vaginal birth after
cesarean (VBAC) deliveries in the United States. Clin Perinatol, 2011. 38(2): 179–92. https://doi.org/
10.1016/j.clp.2011.03.007 PMID: 21645788
6. Martin JA, Hamilton BE, Osterman MJ, Births in the United States, 2015. NCHS Data Brief, 2016(258):
1–8.
7. Kwee A, Bots ML, Visser GH, Bruinse HW, Obstetric management and outcome of pregnancy in
women with a history of caesarean section in the Netherlands. Eur J Obstet Gynecol Reprod Biol, 2007.
132(2): 171–6. https://doi.org/10.1016/j.ejogrb.2006.07.017 PMID: 16904813
8. Melman S., Schoorel EC, de Boer K, Burggraaf H, Derks JB, van Dijk D, et al. Development and Mea-
surement of Guidelines-Based Quality Indicators of Caesarean Section Care in the Netherlands: A
RAND-Modified Delphi Procedure and Retrospective Medical Chart Review. PLoS One, 2016. 11(1):
e0145771. https://doi.org/10.1371/journal.pone.0145771 PMID: 26783742
9. McMahon MJ, Luther ER, Bowes WA Jr, Olshan AF, Comparison of a trial of labor with an elective sec-
ond cesarean section. N Engl J Med, 1996. 335(10): 689–95. https://doi.org/10.1056/
NEJM199609053351001 PMID: 8703167
10. Schoorel EN, van Kuijk SM, Melman S, Nijhuis JG, Smits LJ, Aardenburg R, et al. Vaginal birth after a
caesarean section: the development of a Western European population-based prediction model for
deliveries at term. BJOG, 2014. 121(2): 194–201; discussion 201. https://doi.org/10.1111/1471-0528.
12539 PMID: 24373593
11. Schoorel EN, Vankan E, Scheepers HC, Augustijn BC, Dirksen CD, de Koning M, et al. Involving
women in personalised decision-making on mode of delivery after caesarean section: the development
and pilot testing of a patient decision aid. BJOG, 2014. 121(2): 202–9. https://doi.org/10.1111/1471-
0528.12516 PMID: 24373594
12. Vankan E, Schoorel EN, van Kuijk SM, Mol BJ, Nijhuis JG, Aardenburg R, et al. Practice variation of
vaginal birth after cesarean and the influence of risk factors at patient level: a retrospective cohort
study. Acta Obstet Gynecol Scand, 2016.
13. Kriston L, Scholl I, Holzel L, Simon D, Loh A, Harter M, The 9-item Shared Decision Making Question-
naire (SDM-Q-9). Development and psychometric properties in a primary care sample. Patient Educ
Couns, 2010. 80(1): 94–9. https://doi.org/10.1016/j.pec.2009.09.034 PMID: 19879711
14. Ottawa Health Decision Centre. User manual—decisional conflict scale(s)
15. Montgomery AA, Emmett CL, Fahey T, Jones C, Ricketts I, Patel RR, et al. Two decision aids for mode
of delivery among women with previous caesarean section: randomized controlled trial. BMJ 2007;
334:1305. https://doi.org/10.1136/bmj.39217.671019.55 PMID: 17540908
16. Flamm B.L.,Geiger A.M., Vaginal birth after cesarean delivery: an admission scoring system. Obstet
Gynecol, 1997. 90(6): 907–10. https://doi.org/10.1016/s0029-7844(97)00531-0 PMID: 9397100
17. Gonen R, Tamir A, Degani S, Ohel G, Variables associated with successful vaginal birth after one
cesarean section: a proposed vaginal birth after cesarean section score. Am J Perinatol, 2004. 21(8):
447–53. https://doi.org/10.1055/s-2004-835961 PMID: 15580540
18. Grobman WA, Lai Y, Landon MB, Spong CY, Leveno KJ, Rouse DJ, et al. Development of a nomogram
for prediction of vaginal birth after cesarean delivery. Obstet Gynecol, 2007. 109(4): 806–12. https://
doi.org/10.1097/01.AOG.0000259312.36053.02 PMID: 17400840
19. Grobman WA, Lai Y, Landon MB, Spong CY, Leveno KJ, Rouse DJ et al. Does information available at
admission for delivery improve prediction of vaginal birth after cesarean? Am J Perinatol, 2009. 26(10):
693–701. https://doi.org/10.1055/s-0029-1239494 PMID: 19813165
20. Jakobi P, Weissman A, Peretz BA, Hocherman I, Evaluation of prognostic factors for vaginal delivery
after cesarean section. J Reprod Med, 1993. 38(9): 729–33. PMID: 8254598
21. Macones GA, Hausman N, Edelstein R, Stamilio DM, Marder SJ, Predicting outcomes of trials of labor
in women attempting vaginal birth after cesarean delivery: a comparison of multivariate methods with
neural networks. Am J Obstet Gynecol, 2001. 184(3): 409–13. https://doi.org/10.1067/mob.2001.
109386 PMID: 11228495
22. Metz TD, Stoddard GJ, Henry E, Jackson M, Holmgren C, Esplin S, Simple, validated vaginal birth after
cesarean delivery prediction model for use at the time of admission. Obstet Gynecol, 2013. 122(3):
571–8. https://doi.org/10.1097/AOG.0b013e31829f8ced PMID: 23921867
23. Naji O, Wynants L, Smith A, Abdallah Y, Stalder C, Sayasneh A et al. Predicting successful vaginal birth
after Cesarean section using a model based on Cesarean scar features examined by transvaginal
sonography. Ultrasound Obstet Gynecol, 2013. 41(6): 672–8. https://doi.org/10.1002/uog.12423
PMID: 23371440
Effect of a decision aid on mode of delivery after caesarean
PLOS ONE | https://doi.org/10.1371/journal.pone.0222499 September 26, 2019 14 / 15
24. Pickhardt MG, Martin JN Jr., E.F. Meydrech EF, Blake PG, Martin RW, Perry KG Jr et al., Vaginal birth
after cesarean delivery: are there useful and valid predictors of success or failure? Am J Obstet Gyne-
col, 1992. 166(6 Pt 1): 1811–5; discussion 1815–9. PMID: 1615990
25. Smith GC, White IR, Pell JP, Dobbie R, Predicting cesarean section and uterine rupture among women
attempting vaginal birth after prior cesarean section. PLoS Med, 2005. 2(9): e252. https://doi.org/10.
1371/journal.pmed.0020252 PMID: 16146414
26. Srinivas SK, Stamilio DM, Stevens EJ, Odibo AO, Peipert JF, Macones GA, Predicting failure of a vagi-
nal birth attempt after cesarean delivery. Obstet Gynecol, 2007. 109(4): 800–5. https://doi.org/10.1097/
01.AOG.0000259313.46842.71 PMID: 17400839
27. Tessmer-Tuck JA, El-Nashar SA, Racek AR, Lohse CM, Famuyide AO, Wick MJ, Predicting vaginal
birth after cesarean section: a cohort study. Gynecol Obstet Invest, 2014. 77(2): 121–6. https://doi.org/
10.1159/000357757 PMID: 24525697
28. Troyer LR, Parisi VM, Obstetric parameters affecting success in a trial of labor: designation of a scoring
system. Am J Obstet Gynecol, 1992. 167(4 Pt 1): 1099–104. https://doi.org/10.1016/s0002-9378(12)
80046-9 PMID: 1415398
29. Weinstein D, Benshushan A, Tanos V, Zilberstein R, Rojansky N, Predictive score for vaginal birth after
cesarean section. Am J Obstet Gynecol, 1996. 174(1 Pt 1): 192–8. https://doi.org/10.1016/s0002-9378
(96)70393-9 PMID: 8572005
30. Elwyn G, O’Connor A, Stacey D, Volk R, Edwards A, Coulter A et al., Developing a quality criteria frame-
work for patient decision aids: online international Delphi consensus process. BMJ, 2006. 333(7565):
417. https://doi.org/10.1136/bmj.38926.629329.AE PMID: 16908462
31. Stacey D, Legare F, Col NF, Bennet CL, Barry MJ, Eden KB et al., Decision aids for people facing health
treatment or screening decisions. Cochrane Database Syst Rev, 2014(1): CD001431. https://doi.org/
10.1002/14651858.CD001431.pub4 PMID: 24470076
32. Shorten AB, Shorten B, Keogh J, West S, Morris J, Making choices for childbirth: a randomized con-
trolled trial of a decision-aid for informed birth after cesarean. Birth, 2005. 32(4): 252–61. https://doi.
org/10.1111/j.0730-7659.2005.00383.x PMID: 16336366
33. Montgomery AA, Emmett CL, Fahey T, Jones C, Ricketts I, Patel RR et al., Two decision aids for mode
of delivery among women with previous caesarean section: randomized controlled trial. BMJ, 2007.
334(7607): 1305. https://doi.org/10.1136/bmj.39217.671019.55 PMID: 17540908
34. Horey D, Kealy M, Davey MA, Small R, Crowther CA, Interventions for supporting pregnant women’s
decision-making about mode of birth after a caesarean. Cochrane Database Syst Rev, 2013(7):
CD010041. https://doi.org/10.1002/14651858.CD010041.pub2 PMID: 23897547
35. Gardner K, Henry A, Thou S, Davis G, Miller T, Improving VBAC rates: the combined impact of two
management strategies. Aust N Z J Obstet Gynaecol, 2014. 54 (4): 327–32. https://doi.org/10.1111/
ajo.12229 PMID: 25117188
Effect of a decision aid on mode of delivery after caesarean
PLOS ONE | https://doi.org/10.1371/journal.pone.0222499 September 26, 2019 15 / 15
